Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaolin Huang

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Medicine|April 14, 2022
Effect of Direct Bilirubin Level on Clinical Outcome and Prognoses in Severely/Critically Ill Patients With COVID-19Wensen Chen, Hanting Liu, Gang Yang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 25, 2025
Piplartine alleviates sepsis-induced acute kidney injury by inhibiting TSPO-mediated macrophage pyroptosisRui Gong, Gangyu Long, Qian Wang, et al.
Frontiers in Microbiology|December 24, 2021
Recent Advances in Bunyavirus Reverse Genetics Research: Systems Development, Applications, and Future PerspectivesFuli Ren, Shu Shen, Qiongya Wang, et al.
Journal of Human Evolution|March 18, 2014
Middle Pleistocene bifaces from Fengshudao (Bose Basin, Guangxi, China)Wei Wang, Christopher J Bae, Shengmin Huang, et al.
Virologica Sinica|September 1, 2020
Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective StudyYongran Wu, Ke Hong, Lianguo Ruan, et al.
Antiviral Research|February 3, 2023
Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71Guangyan Zhu, Chengyuan Wu, Qian Wang, et al.
Virology Journal|July 27, 2025
Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathwayJie Zhou, Yanping Wang, Guangyan Zhu, et al.
Virologica Sinica|February 9, 2021
Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort StudyBali Zhao, Maohua Zhong, Qingyu Yang, et al.
Oncotarget|February 1, 2018
Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E<sub>2</sub> and down-regulating the Wnt pathway activityChaolin Huang, Yuanhong Chen, Hang Liu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2021
High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TBQi Nie, Lixuan Tao, Yingying Li, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Medicine|April 14, 2022
Effect of Direct Bilirubin Level on Clinical Outcome and Prognoses in Severely/Critically Ill Patients With COVID-19Wensen Chen, Hanting Liu, Gang Yang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 25, 2025
Piplartine alleviates sepsis-induced acute kidney injury by inhibiting TSPO-mediated macrophage pyroptosisRui Gong, Gangyu Long, Qian Wang, et al.
Frontiers in Microbiology|December 24, 2021
Recent Advances in Bunyavirus Reverse Genetics Research: Systems Development, Applications, and Future PerspectivesFuli Ren, Shu Shen, Qiongya Wang, et al.
Journal of Human Evolution|March 18, 2014
Middle Pleistocene bifaces from Fengshudao (Bose Basin, Guangxi, China)Wei Wang, Christopher J Bae, Shengmin Huang, et al.
Virologica Sinica|September 1, 2020
Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective StudyYongran Wu, Ke Hong, Lianguo Ruan, et al.
Antiviral Research|February 3, 2023
Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71Guangyan Zhu, Chengyuan Wu, Qian Wang, et al.
Virology Journal|July 27, 2025
Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathwayJie Zhou, Yanping Wang, Guangyan Zhu, et al.
Virologica Sinica|February 9, 2021
Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort StudyBali Zhao, Maohua Zhong, Qingyu Yang, et al.
Oncotarget|February 1, 2018
Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E<sub>2</sub> and down-regulating the Wnt pathway activityChaolin Huang, Yuanhong Chen, Hang Liu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2021
High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TBQi Nie, Lixuan Tao, Yingying Li, et al.
Pageof 9